Beijing Sciecure Pharmaceutical Co., Ltd. was established in April 2002 and re-structured its equity in 2007. The company formed a R&D laboratory in New Jersey, USA in 2012, and the business offices in USA in 2013, UK and Canada in 2014.The campus at Beijing site,with more than 400 employees and covering 94,000 square meters, is a national high tech pharmaceutical enterprise with the innovation strategy of new technology, new productsand new process, and was awarded as High-Tech Corporation by Beijing Municipal committee of Science and Technology.Since the first day, Beijing Sciecure Pharmaceutical Co., Ltd. has been collaborated with many universities and research institutes, such as Peking University, Tsinghua University, Beijing University of Chemical Technology, Institute of Materia Medica of Chinese Academy of Medical Sciences, Shenyang Pharmaceutical University, Academy of Military Medical Sciences, etc., to form the unity of the research, teaching, and manufacturing. Company has now five innovativedrugs with about 30 patentsas well as other 50 more either new drugs or generic drugs under the development.Beijing Sciecure Pharmaceutical Co., Ltd. now has the advanced facilities of ampoules, vials for injection, OSD, lyophilization, LVP, and API. All production lines are designed with the CFDA, US FDA, and EU GMP philosophy and operated with the automatic control systems, such as MES, SCADA, DCS,PLC, and BMS, etc.Our production lines, warehouse, R&D and QC laboratories have been installed by the state-of-the-art instruments/equipmentfor daily operation.Sciecure understands that only high level of quality and service are accepted. Company recruits and retains a globalized management team with GMP and R&D experience.